{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:54:36Z","timestamp":1791258876329,"version":"4.1.0"},"reference-count":125,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2015,11,2]]},"DOI":"10.1517\/13543776.2015.1076394","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:48:40Z","timestamp":1770407320000},"page":"1267-1284","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Glycation, carbonyl stress and AGEs inhibitors: a patent review"],"prefix":"10.1517","volume":"25","author":[{"given":"Humera","family":"Jahan","sequence":"first","affiliation":[{"name":"University of Karachi, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Iqbal","family":"Choudhary","sequence":"additional","affiliation":[{"name":"University of Karachi, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences","place":["Pakistan"]},{"name":"University of Karachi, H.E.J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"e_1_3_2_3_1","first-page":"66","article-title":"Action of amino acids on sugars. Formation of melanoidins in a methodical way","volume":"154","author":"Maillard LC","year":"1912","unstructured":"Maillard LC. Action of amino acids on sugars. Formation of melanoidins in a methodical way. Compt Rend 1912;154:66-8","journal-title":"Compt Rend"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408398909527499"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200500034"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200600304"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2014.00009"},{"key":"e_1_3_2_8_1","volume-title":"Age Related Macular Degeneration: The Recent Advances in Basic Research and Clinical Care","author":"Kaji Y","year":"2012","unstructured":"Kaji Y, Oshika T, Fujii N. Non-Enzymatic Post-Translational Modifications in the Development of Age-Related Macular Degeneration. Age Related Macular Degeneration: The Recent Advances in Basic Research and Clinical Care. In Tech; Europe: 2012"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450111009011468"},{"key":"e_1_3_2_10_1","volume-title":"The Future of Aging: Pathways to Human Life Extension","author":"Furber JD","year":"2010","unstructured":"Furber JD. Repairing Extracellular Aging and Glycation. The Future of Aging: Pathways to Human Life Extension. Springer Science+Business Media B.V; London, USA: 2010"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621854"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986710791331086"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1039\/c1fo10026b"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2484"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197608192950804"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2006.05.016"},{"key":"e_1_3_2_17_1","first-page":"1942","article-title":"Protein glycation: biochemical-clinical correlations","volume":"37","author":"Deo SK","year":"2013","unstructured":"Deo SK, Pandey R, Singh J, et al. Protein glycation: biochemical-clinical correlations. J Pharm Biomed Sci 2013;37:1942-7","journal-title":"J Pharm Biomed Sci"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2004.09.004"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051591"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2013.11.006"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.1.1"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V104822"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(95)02054-3"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000424089"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1157"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)31635-1"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.30.18714"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70189-2"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)89188-3"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0308-8146(98)00078-8"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665199000762"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2010.03.018"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6474"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.6.1308"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080152"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.13915"},{"key":"e_1_3_2_37_1","first-page":"1025","article-title":"Advanced glycation end products and cigarette smoking","volume":"44","author":"Nicholl ID","year":"1998","unstructured":"Nicholl ID, Bucala R. Advanced glycation end products and cigarette smoking. Cell Mol Biol 1998;44:1025-33","journal-title":"Cell Mol Biol"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222561699"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2005.76.7.1171"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.19.8807"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118175"},{"key":"e_1_3_2_42_1","first-page":"325","article-title":"Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina","volume":"75","author":"Hammes HP","year":"1996","unstructured":"Hammes HP, Weiss A, Hess S, et al. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest 1996;75:325-38","journal-title":"Lab Invest"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1996.0308"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.46.1.223"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(88)90015-0"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)42287-9"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.3.1301"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc3801.097806"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9441"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.6.1331"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1002089"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.7.807"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115014"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115928"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117296"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.7.2262"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)00731-0"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.05.001"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1451-2"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242407999"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-010-0434-5"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.491"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1810-7"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/089686080502500603"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1333.030"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.11.3103"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2173"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464050-00001"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2003.08.009"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3487117"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00287-2"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.501"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.4.552"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1120781"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00263-4"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.4.405"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0531-5131(02)00889-0"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00809-9"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07977.x"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2003.08.010"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108196200"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200208000-00024"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.01.007"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000069362.52165.C9"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000065620.39919.20"},{"key":"e_1_3_2_86_1","first-page":"441","article-title":"Influence of penicillamine on the formation of early non-enzymatic glycation products of human serum proteins","volume":"30","author":"Keita Y","year":"1992","unstructured":"Keita Y, Michailova M, Kratzer W, et al. Influence of penicillamine on the formation of early non-enzymatic glycation products of human serum proteins. Int J Clin Pharmacol Ther Toxicol 1992;30:441-2","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00462-2"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-005-0688-7"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2004.12.016"},{"key":"e_1_3_2_90_1","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng AL","year":"2001","unstructured":"Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-900","journal-title":"Anticancer Res"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013106527829"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00237-8"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf9007168"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.06.077"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf071770y"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(96)00377-2"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00658-X"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.1.68"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00401418"},{"key":"e_1_3_2_100_1","unstructured":". Al-Resayes SI Warad I Al-Nuri MA et al.et al. Heterocyclic Schiff\u2019s bases as novel and new antiglycation agents. US20140221429A1; 2014"},{"key":"e_1_3_2_101_1","volume-title":"Preparation and Characterization Urea-Solubilized SolGel Type I Collagen and Its Possible Use in Applications, Regenerative Medicine and Tissue Engineering Cells and Biomaterials","author":"Xiong, Herwig Brunner and Robin Ghosh (2011)","unstructured":"Xiong, Herwig Brunner and Robin Ghosh (2011). Preparation and Characterization Urea-Solubilized SolGel Type I Collagen and Its Possible Use in Applications, Regenerative Medicine and Tissue Engineering Cells and Biomaterials. In: Prof Daniel Eberli, Editor ISBN: 978-953-307-663-8: InTech"},{"key":"e_1_3_2_102_1","unstructured":"Derbre S Morel S Richomme P et al. Laboratory Shigeta Universite D\u2019angers. Anti-glycation agent comprising a Garcinia Kola extract or fraction. EP2735312A1; 2014"},{"key":"e_1_3_2_103_1","unstructured":"Hudson Billy G Gabriel KR Parvin T et al. Kansas University Medical Center. Advanced glycation end-product intermediaries and post-amadori inhibition. US5985857A; 1999"},{"key":"e_1_3_2_104_1","unstructured":"Khalifah RG Marti RE. Nephro Genex Inc. Inhibitors of advanced glycation end products. US20140187506A1; 2014"},{"key":"e_1_3_2_105_1","unstructured":"Li L Sungha P Wen W et al. The United State of America. Human soluble receptor for advanced glycation end products (sRAGE) methods of preparing human sRAGE and treatment methods using sRAGE. EP2650013A1; 2013"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl735"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-006-0083-y"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(00)00240-0"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18600"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000178769.52610.69"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00398.2004"},{"key":"e_1_3_2_112_1","unstructured":"Rahbar S. City of Hope. Breakers of advanced glycation endproducts. US6787566B2; 2004"},{"key":"e_1_3_2_113_1","unstructured":"Rahbar S Figarola JL. City of Hope. Use of LR-90 and LR-102 to overcome insulin resistance. US008124655B2; 2012"},{"key":"e_1_3_2_114_1","unstructured":"Schmidt AM Stern DM. The Trustees of Columbia University. RAGE G82S-related methods and compositions for treating inflammatory disorders. US008067371B2; 2011"},{"key":"e_1_3_2_115_1","unstructured":"Lalezari I Rahbar S. City of Hope. Novel inhibitors of advanced glycation endproducts (AGES). EP1594492B1; 2008"},{"key":"e_1_3_2_116_1","unstructured":"Potier P Zelveyan MDM Potier P Germain M. AGE inhibitors. US20080249030A1; 2008"},{"key":"e_1_3_2_117_1","unstructured":"Rahbar S Natarajan R. City of Hope. Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitors. US8580854B2; 2007"},{"key":"e_1_3_2_118_1","unstructured":"Hudson B Voziyan P Ikizler A. Vanderbilt University. Use of pyridoxamine to treat and\/or prevent disease processes. US20070238761A1; 2007"},{"key":"e_1_3_2_119_1","unstructured":"Rahbar S Lalezari I. City of Hope. Inhibitors of formation of advanced glycation endproducts (AGEs). US7030133B2; 2006"},{"key":"e_1_3_2_120_1","unstructured":"Morariu M; Tracie Martyn International Llc. Topical compositions comprising benfotiamine and pyridoxamine. US766644B2; 2006"},{"key":"e_1_3_2_121_1","unstructured":"Hudson BG Todd P Khalifah RG et al. Kansas University Medical Center. Advanced glycation end-product intermediaries and post-amadori inhibition. US6750209B1; 2004"},{"key":"e_1_3_2_122_1","unstructured":"Baynes JW Thorpe SR Degenhardt TP et al. Kansas University Medical Center University of South Carolina. Methods for inhibiting diabetic complications. US006740668B1; 2004"},{"key":"e_1_3_2_123_1","unstructured":"Baynes JW Onorato J Thorpe S et al. Kansas University Medical Center University of South Carolina. Methods for inhibiting oxidative modification of proteins. US006730686B1; 2004"},{"key":"e_1_3_2_124_1","unstructured":"Rahbar S Nadler JI. City of Hope. Pentoxifylline pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE\u2019S). US006693106B2; 2004"},{"key":"e_1_3_2_125_1","unstructured":"Rahbar S Lalezari I. City of Hope. Inhibitors of formation of advanced glycation endproducts (AGEs). US6605642B2; 2003"},{"key":"e_1_3_2_126_1","unstructured":"Rahbar S Lalezari I. City of Hope. Inhibitors of formation of advanced glycation endproducts (AGEs). US6337350B1; 2002"},{"key":"e_1_3_2_127_1","unstructured":"European Patent Office database. Available from: http:\/\/ep.espacenet.com\/"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543776.2015.1076394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:48:43Z","timestamp":1770407323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543776.2015.1076394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":125,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11,2]]}},"alternative-id":["10.1517\/13543776.2015.1076394"],"URL":"https:\/\/doi.org\/10.1517\/13543776.2015.1076394","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}